Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;109(11S):11S11-11S20.
doi: 10.1016/S0007-4551(22)00464-7.

Apport de l'immunothérapie dans le traitement des cancers des voies biliaires avancés

[Article in French]
Matthieu Delaye  1 , Astrid Lièvre  2 , Cindy Neuzillet  3
Affiliations
Free article
Review

Apport de l'immunothérapie dans le traitement des cancers des voies biliaires avancés

[Article in French]
Matthieu Delaye et al. Bull Cancer. 2022 Nov.
Free article

Abstract

Contribution of immunotherapy in the treatment of advanced biliary tract cancer Biliary tract cancers (BTC) are rare tumors with a poor prognosis. Their treatment, at an advanced stage, relies on combinations of chemotherapies, which have a limited range and duration of benefit. Immunotherapy has emerged in recent years as a new therapeutic approach for BTC. However, the benefit with currently available treatments seems more modest than in other tumor locations and the predictive markers of response to these treatments remain to be identified. This review article summarizes the rationale, current data, and prospects and challenges for the development of immunotherapy in BTC.

Keywords: Biliary tract cancer; Biomarkers; Biomarqueurs; Cancers des voies; Immunotherapy; Immunothérapie; biliaires.

PubMed Disclaimer